definiens: shall mean ( a ) any Backup Compound Candidate incorporated in a productadministered to subjects in a first - in - human Clinical Trial or any Clinical Trial conducted under the R&D Plan, in eachcase for a Permitted Indication or ( b ) any other composition [ * * * ] ( and no [ * * * ] ) as a Backup Compound Candidatedescribed in clause ( a ) of this Section 1.14 ( including, for example, a composition [ * * * ] ( and no [ * * * ] ) as acomposition described in ( a ) but differing [ * * * ] ) . A Backup Compound Candidate shall be a andno longer a at the time that such Backup Compound Candidate is administered to asubject in a first - in - human Clinical Trial or other Clinical Trial conducted under the R&D Plan . For clarity, [ * * * ] IND